US EPA

502232 

Journal Article 

Bruton's tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain 

Mohamed, AJ; Yu, L; Backesjo, CM; Vargas, L; Faryal, R; Aints, A; Christensson, B; Berglof, A; Vihinen, M; Nore, BF; Smith, CIE 

2009 

Yes 

Immunological reviews
ISSN: 0105-2896
EISSN: 1600-065X 

228 

58-73 

English 

Bruton's agammaglobulinemia tyrosine kinase (Btk) is a cytoplasmic tyrosine kinase important in B-lymphocyte development, differentiation, and signaling. Btk is a member of the Tec family of kinases. Mutations in the Btk gene lead to X-linked gammaglobulinemia (XLA) in humans and X-linked immunodeficiency (Xid) in mice. Activation of Btk triggers a cascade of signaling events that culminates in the generation of calcium mobilization and fluxes, cytoskeletal rearrangements, and transcriptional regulation involving nuclear factor-kappa B (NF-kappa B) and nuclear factor of activated T cells (NFAT). In B cells, NF-kappa B was shown to bind to the Btk promoter and induce transcription, whereas the B-cell receptor-dependent NF-kappa B signaling pathway requires functional Btk. Moreover, Btk activation is tightly regulated by a plethora of other signaling proteins including protein kinase C (PKC), Sab/SH3BP5, and caveolin-1. For example, the prolyl isomerase Pin1 negatively regulates Btk by decreasing tyrosine phosphorylation and steady state levels of Btk. It is intriguing that PKC and Pin1, both of which are negative regulators, bind to the pleckstrin homology domain of Btk. To this end, we describe here novel mutations in the pleckstrin homology domain investigated for their transforming capacity. In particular, we show that the mutant D43R behaves similar to E41K, already known to possess such activity 

x-linked agammaglobulinemia; b-cell receptor; pleckstrin homology; domain; transcription factor bright; tec family kinases; factor-kappa-b; acute lymphoblastic-leukemia; proline-rich sequences; t-cell; sh3 domain